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The feline immunodeﬁciency virus (FIV) envelope glycoprotein (Env) possesses a short cytoplasmic
domain of 53 amino acids containing four highly conserved cysteines at Env positions 804, 811, 815 and
848. Since palmitoylation of transmembrane proteins occurs at or near the membrane anchor, we
investigated whether cysteines 804, 811 and 815 are acylated and analyzed the relevance of these
residues for Env functions. Replacement of cysteines 804, 811 and 815 individually or in combination
by serine residues resulted in Env glycoproteins that were efﬁciently expressed and processed.
However, mutations C804S and C811S reduced Env fusogenicity by 93% and 84%, respectively,
compared with wild-type Env. By contrast, mutant C815S exhibited a fusogenic capacity representing
50% of the wild-type value. Remarkably, the double mutation C804S/C811S abrogated both Env fusion
activity and Env incorporation into virions. Finally, by means of Click chemistry assays we demon-
strated that the four FIV Env cytoplasmic cysteines are palmitoylated.
& 2012 Elsevier Inc. All rights reserved.Introduction
A number of cellular and viral proteins have been found to be
modiﬁed by the covalent addition of the 16-carbon saturated
fatty acid palmitate (Smotrys and Linder, 2004). Palmitoylation of
transmembrane proteins consists in the attachment of palmitic
acid via a thioester group to cysteine residues within or at
close proximity to the membrane-spanning domain (Resh, 2006;
Smotrys and Linder, 2004).
Protein palmitoylation differs from other types of fatty acylation
such as prenylation and myristoylation. There is no clear consensus
sequence for protein palmitoylation that would allow the identiﬁca-
tion of potential addition sites by simple examination of the protein
primary structure. The most practical approach is to determine if
mutagenesis of the cysteine residues at or near the proteinmembrane
anchor affects protein palmitoylation (Drisdel et al., 2006). Another
distinctive feature of protein palmitoylation is that it is a reversible
process. Indeed, speciﬁc enzymes that catalyze protein palmitoylation
or depalmitoylation have been identiﬁed and characterized in yeast
and human cells (see references in Drisdel et al., 2006).
Based on the high hydrophobic character of palmitic acid and on
the fact that protein palmitoylation is a dynamic process, several
functions have been attributed to this particular kind of fattyll rights reserved.
.edu.ar,acylation. It has been shown that palmitoylation targets proteins
to lipid rafts, speciﬁc membrane microdomains that are enriched in
cholesterol and glycosphingolipids. This is the case of the inﬂuenza
virus hemagglutinin which requires three palmitoylated cysteines
for efﬁcient association with lipid rafts (Melkonian et al., 1999) and
of the luteinizing hormone receptor which localizes to lipid rafts
only after palmitate addition to its C-terminus (Lei et al., 2005).
Moreover, the reversibility of palmitate attachment to proteins has
led to the proposal that this modiﬁcation plays a critical role in the
regulation of protein function and cell signaling, as it has been
shown for cell surface receptors and ion channels (Chien et al., 1996;
Drisdel et al., 2004).
Retroviruses possess a single envelope glycoprotein (Env), a
heterodimer composed of the surface (SU) and transmembrane
(TM) subunits that are associated by non-covalent interactions.
Several retroviral glycoproteins have been found to be palmitoy-
lated. In both Friend and Moloney murine leukemia viruses (F-MuLV
and M-MuLV, respectively) palmitoylation occurs at the cysteine
residue within the TM membrane-spanning domain (Hensel et al.,
1995; Yang and Compans, 1996). In M-MuLV substitution of this
cysteine with serine reduces Env association with lipid rafts,
although it should be taken into account that this mutation also
impairs Env transport to the cell surface (Li et al., 2002).
Within the membrane anchor region of the Rous sarcoma virus
(RSV) TM glycoprotein, the cysteines at positions 164 and 167 are the
sites of palmitate addition (Ochsenbauer-Jambor et al., 2001). Repla-
cement of cysteine 167 by glycine results in the formation of poorly
infectious virions due to an impairment in Env incorporation into
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being palmitoylated, the RSV Env glycoprotein does not appear to
partition into membrane lipid rafts (Ochsenbauer et al., 2000).
In the case of human and simian immunodeﬁciency viruses (HIV
and SIV, respectively), their TM cytoplasmic domains have also been
found to be palmitoylated. However, in contrast to other glycopro-
teins which are S-acylated at cysteine residues located near or within
the membrane anchor, addition of palmitate to the HIV-1 Env protein
of the HXB2 strain takes place at cysteines 764 and 837 which are
located at a distance of 59 and 132 amino acids, respectively, from the
cytoplasmic side of the proposed membrane-spanning domain (Yang
et al., 1995). With respect to SIV, palmitic acid has been found to be
attached to cysteine 787 in the cytoplasmic domain of the SIVmac239
Env glycoprotein (Yang et al., 1995). Cysteine 787 is at a distance of
71 residues from the C-terminus of the membrane anchor. The fact
that HIV-1 and SIV Env proteins are palmitoylated at sites distantly
located from the TM membrane-spanning domain may reﬂect that
these primate lentiviral glycoproteins exhibit unusually long cyto-
plasmic tails, the structure of which has not as yet been resolved.
HIV-1 possesses a TM cytoplasmic domain of 150 residues whereas
that of SIV is 164 amino acids long.
For HIV-1, partially contradictory results have been reported
regarding the effect on Env functions of eliminating the TM
palmitoylation sites. Rousso et al. (2000) have shown that removal
of both palmitoylation sites in the HIV-1 Env cytoplasmic domain
results in decreased Env association with lipid rafts, inhibition of Env
incorporation into virions and a 60-fold reduction in viral infectivity.
Based on the fact that several infectious HIV-1 molecular clones do
not contain cysteines in their Env cytoplasmic domains, two other
groups further examined whether Env palmitoylation plays any role
in viral infectivity. Using the HIV-1 NL4-3 strain, which conserves
the cysteine residue at position 764 but exhibits a tyrosine at
position 837, Bhattacharya et al. (2004) have shown that substitu-
tion of cysteine 764 and tyrosine 837 by serines or alanines inhibits
Env localization in lipid rafts and reduces both Env incorporation
and viral infectivity. However, HIV-1 Env mutants carrying at
positions 764 and 837 amino acids with bulky hydrophobic side
chains, such as phenylalanine and tyrosine, exhibit an infectivitySU
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Fig. 1. Schematic diagram of wild-type (WT) and mutant FIV Env proteins. The FIV Env g
and TM subunits. The TM regions are highlighted: ectodomain (black box), membrane
corresponds to the Env protein of the Petaluma F-14 isolate. The different Env mutants
were replaced alone or in combination by serines, are indicated.capacity representing approximately 80% of that of wild-type
viruses (Bhattacharya et al., 2004). In this regard, it should be
emphasized that those HIV-1 isolates lacking cysteines in their
Env cytoplasmic tails bear hydrophobic amino acids with bulky side
chains at positions 764 and 837. Surprisingly, Chan et al. (2005)
have reported that Cys-to-Ser mutations at HIV-1 Env positions 764
and 837 do not affect either Env cell surface expression or Env
incorporation into virions. Moreover, this Env mutant virus efﬁ-
ciently replicates in CD4þ T cells (Chan et al., 2005).
Feline immunodeﬁciency virus (FIV) is a lentivirus that induces
in cats a syndrome similar to human AIDS caused by HIV (Pedersen
et al., 1987). A distinctive feature of the FIV Env protein is that
it exhibits a cytoplasmic domain of 53 amino acids, which is
signiﬁcantly shorter than those of the rest of the lentiviral Env
glycoproteins that exceed the size of 100 residues (Verschoor et al.,
1993). We have previously shown that the FIV Env cytoplasmic
domain plays an important role in regulating Env-mediated viral
functions (Celma et al., 2007). Indeed, progressive truncation of the
FIV Env cytoplasmic tail from its C-terminus drastically affects either
positively or negatively Env fusogenic activity and Env incorporation
into virions (Celma et al., 2007).
The cytoplasmic domain of FIV Env has three highly conserved
cysteine residues in close proximity to the TM membrane anchor.
The disparate data regarding the relevance of Env palmitoylation for
HIV-1 replication, prompted us to investigate the role in Env
biological properties of the membrane-proximal cysteines within
the FIV Env cytoplasmic domain. Furthermore, we examined whether
the FIV Env protein is modiﬁed by the addition of palmitate.Results
Mutagenesis of the conserved cysteine residues in the cytoplasmic
domain of FIV Env
The cytoplasmic domain of the FIV TM glycoprotein exhibits
four cysteines at Env positions 804, 811, 815 and 848 which are
highly conserved among viral isolates (Fig. 1). Cysteı´nes 804, 811611 856
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lycoprotein is depicted at the top showing the cleavage site (arrow) between its SU
anchor (gray box) and cytoplasmic domain (white box). Amino acid numbering
used in this study, in which the membrane-proximal cysteines 804, 811 and 815
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spanning domain, whereas cysteine 848 is at a distance of only
8 amino acids from the Env C-terminus (Fig. 1). We therefore
speculated that, due to their location, cysteines 804, 811 and 815
could be potential sites for protein palmitoylation. To examine
the relevance of these membrane-proximal cysteines for Env
biological properties, we performed a site-directed mutagenesis
study in which we ﬁrst replaced, alone or in combination, the
conserved cysteine residues by serines and then analyzed the
effect of these amino acid changes on Env-mediated viral func-
tions. The substitution of a cysteine residue for a serine residue
only replaces the thiol group of the former amino acid with a
hydroxyl group thereby minimizing the effect of the mutation on
the overall protein structure.
We generated three single mutants (C804S, C811S and C815S),
two double mutants (C804S/C811S and C811S/C815S) and a triple
mutant in which all three cysteines were replaced by serines
(Fig. 1).Synthesis and processing of mutant Env glycoproteins
We ﬁrst investigated whether mutation of the TM cysteines
804, 811 and 815 affects Env expression or processing. Crandell
feline kidney (CrFK) cells were transfected with the wild-type
proviral DNA or the FIV genomes carrying the single, double or
triple Cys-to-Ser mutations. Immunoblotting of the cell lysates
and the clariﬁed supernatants with anti-SU and anti-TM speciﬁc
antibodies revealed that all mutant Env glycoproteins were
expressed and processed as efﬁciently as wild-type Env (Fig. 2).
Indeed, the mutant Env precursors as well as their SU and TM
subunits were clearly detected in cell lysates (Fig. 2A and C). An
increase in SU shedding with respect to that of wild-type Env was
only observed for the C815S and C804S/C811S mutants when
the cell-free supernatants were analyzed for the presence of
SU (Fig. 2B). Quantitation of the SU levels in the culture super-
natants of cells expressing wild-type Env or mutant C815S and105
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Fig. 2. Synthesis and processing of the FIV Env mutants. CrFK cells were transfected w
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the anti-SU MAb (B). The mobilities of the Env precursor (Pre), SU and TM subunits ar
molecular weight standards (in kDa) are also included.C804S/C811S glycoproteins showed an increase of 1.970.1 and
2.470.2 for the C815S and C804S/C811S mutants, respectively,
when compared to wild-type Env (mean7SD, three independent
assays). Our results indicate that mutation of TM cysteines
804, 811 or 815 does not signiﬁcantly affect Env synthesis or
processing.Cell–cell fusion mediated by mutant FIV Env glycoproteins
To evaluate the effect of replacing TM cysteines 804, 811 or 815
by serines on Env fusion activity, we conducted a syncytium
formation assay. We have recently developed for the Env protein
of the FIV Petaluma isolate a sensitive and quantitative method that
assesses fusion between FIV Env-expressing cells and human CXCR4
cells (Celma et al., 2007). 293T cells were cotransfected with the
wild-type or TM mutant pcDNAFIVDU3 proviral DNAs and the
plasmid encoding the HIV-1 Tat protein (see ‘‘Materials and meth-
ods’’). 48 h post-transfection, the cells were dissociated and added to
TZM-bl indicator cells. After 48 h of coculture, cells were stained for
b-galactosidase activity and scored for syncytia formation. This cell–
cell fusion assay is based on the facts that the FIV Petaluma isolate
is independent of the CD134 primary receptor for cell entry
(Shimojima et al., 2004) and that FIV can efﬁciently use human
CXCR4 (Poeschla and Looney, 1998; Willett et al., 1997).
Under the experimental conditions described above, 293T cells
expressing wild-type Env yielded 763769 blue syncytia per well
(average of three independent experiments,7SD). When we exam-
ined the fusion ability of the mutant Env glycoproteins we found
that mutations C804S and C811S signiﬁcantly impaired Env fuso-
genicity. Indeed, mutant Env proteins C804S and C811S exhibited
fusogenic capacities representing only 16% and 7.6%, respectively, of
the wild-type value (Table 1). By contrast, mutation C815S allowed
substantial Env fusion activity; mutant C815S retained 50% fuso-
genic capacity when compared to wild-type Env (Table 1). The most
drastic effect on cell–cell fusion was observed for the double (C804S/
C811S and C811S/C815S) and triple (C804S/C811S/C815S) mutants.C8
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ith the wild-type (WT) or mutant proviral DNAs. At 48 h post-transfection, viral
lotting using different antibodies. Cell lysates were probed with a MAb directed to
peciﬁc for the FIV capsid protein (D; anti-CA). The supernatants were reacted with
e indicated as are those of the Gag and capsid (CA) proteins. The positions of the
Table 1
Cell-to-cell fusion mediated by FIV Env mutant glycoproteins.a
Env glycoprotein Relative fusion (% wild-type)b
Wild-type 100
Wild-typeþAMD3100 (50mg/ml) 0.370.1
C804S 16.272.7
C811S 7.671.4
C815S 52.277.0
C804S/C811S 0.770.3
C811S/C815S 3.970.7
C804S/C811S/C815S 0.370.1
a 293T cells expressing the wild-type or the mutant FIV Env glycoproteins
together with HIV-1 Tat protein were dissociated and equivalent numbers of
cells were added at 1:5 ratio to 4104 TZM-bl cells. Coculture was continued for
48 h, after which cells were stained for b-galactosidase and scored for syncytia
formation. A fraction of the transfected 293T cells was subjected to immunoblot-
ting to monitor Env expression.
b Data presented were obtained from three independent experiments, and
each assay was performed in triplicate. Blue foci were quantitated as described in
‘‘Materials and methods’’. Values represent means7standard deviations.
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Fig. 3. Cell surface expression of FIV Env mutants. (A) The surface levels in 293T
cells of the wild-type and mutant Env glycoproteins were quantitated by cellular
ELISA as described in ‘‘Materials and methods’’. The values (mean7SD, three
independent analyses) correspond to the absorbance of each sample at 405 nm
from which the absorbance of non-transfected cells incubated only with the
secondary antibody was subtracted. (B) Relative cell surface levels of mutant
Env glycoproteins expressed as percentages of those of wild-type Env (considered
as 100%). Data were calculated from the values shown in panel A. (C) Cells
transfected with the wild-type or the mutant proviral DNAs were ﬁxed and
permeabilized and total FIV Env glycoprotein levels were determined by cellular
ELISA. Values represent percentages of that of wild-type Env (considered as 100%).
Data correspond to the mean7SD of three independent experiments.
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(Table 1). It should be mentioned that the fusion assay used in these
experiments is speciﬁc for the Env-CXCR4 interaction since addition
of the CXCR4 antagonist AMD3100 (50 mg/ml) almost completely
inhibits wild-type Env fusion activity (Table 1). Our results therefore
demonstrate that, although mutation of any of the TM cysteines at
positions 804, 811 and 815 reduces Env-mediated membrane fusion,
replacement of cysteines 804 and 811 by serine is highly detri-
mental to this Env property.
Cell surface expression of FIV Env mutants
Since mutations C804S C811S severely inhibited Env fusogeni-
city, we decided to examine whether this defect was secondary to
an impairment in Env transport to the plasma membrane. We
therefore determined the steady-state levels on the cell surface of all
the mutant Env glycoproteins and compared them with those of
wild-type FIV Env using cellular enzyme-linked immunosorbent
assay (cellular ELISA). This technique is highly sensitive and speciﬁc
for the quantitative analysis of molecules expressed on the cell
surface (Jo´zefowski et al., 2011; Lourenc-o and Roque-Barreira,
2010). 293T cells expressing the wild-type or mutant Env glycopro-
teins were incubated ﬁrst with the anti-SU monoclonal antibody
(MAb) and then with a horseradish peroxidase (HRP)-coupled
secondary antibody as described in ‘‘Materials and methods’’. As
shown in Fig. 3A and B, the Envmutants C804S, C811S, C804S/C811S
and C804S/C811S/C815S were present at the plasma membrane at
levels ranging from 92% to 101% of those of wild-type Env, whereas
mutant C811S/C815 attained cell surface levels representing 125% of
the wild-type value. By contrast, mutation C815S caused a 24%
reduction in Env cell surface expression (Fig. 3A and B).
When Env expression was assessed by ELISA after ﬁxation and
permeabilization of the transfected cells, we found that all Cys-to-
Ser TM mutants showed levels of total Env protein similar to or
even higher than those of wild-type Env (Fig. 3C).
To corroborate that cellular ELISA only quantiﬁes cell surface
molecules (Jo´zefowski et al., 2011; Lourenc-o and Roque-Barreira,
2010), we applied this methodology to 293T cells using as
primary antibody a MAb speciﬁc for a-tubulin as explained in
‘‘Materials and methods’’. As expected, the absorbance obtained
with this primary antibody was similar to the background values
obtained with cells incubated only with the secondary antibody.
By contrast, a-tubulin was readily detected and quantitated when
the cellular ELISA was performed with ﬁxed and permeabilizedcells. Indeed, the A405 for a-tubulin in intact cells was 0.0970.02
while that in permeabilized cells was 0.8470.09 (mean of three
independent experiments7SD).
In conclusion, our results demonstrate that the FIV Env mutant
glycoproteins are as efﬁciently expressed on the cell surface
as wild-type Env. Only in the case of the C815S mutant, a
modest reduction in the levels of surface-associated glycoprotein
is observed.
Incorporation of the FIV Env mutants into virions
We next examined whether the Cys-to-Ser substitutions
introduced into the TM cytoplasmic domain affect Env incorpora-
tion into virions. CrFK cells were transfected with the wild-type,
C804S, C811S, C815S, C804S/C811S or C804S/C811S/C815S pro-
viral DNAs and virions were then puriﬁed from the cell culture
S.A. Gonza´lez et al. / Virology 428 (2012) 1–10 5supernatants. The viral proteins were resolved by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), blotted
and probed for the TM and capsid (CA) proteins as described in
‘‘Materials and methods’’. To evaluate the ability of each mutant
Env glycoprotein to associate with particles, virions were tested
for the presence of the TM protein instead of the SU subunit
because the latter can be spontaneously shed from the cell surface
of the transfected cells and therefore contaminate the particulate
fraction (Celma et al., 2001). As shown in Fig. 4A, replacement of
cysteines 804, 811 or 815 by a serine residue did not affect Env
packaging into virions. By contrast, the Env glycoproteins carrying
either the double mutation C804S/C811S or the triple substitution
C804S/C811S/C815S were not incorporated into particles (Fig. 4B).
Indeed, the TM proteins of these mutants could not be detected in
the particulate fraction despite the fact that the levels of virion-
associated CA protein observed for these mutant viruses were
similar to those of their wild-type counterpart (Fig. 4A and B).
Biotinylation experiments of CrFK cells expressing the wild-
type Env or the mutant glycoproteins C804S, C811S, C815S
and C804S/C811S/C815S demonstrated that the levels of cell
surface-associated Env precursor and SU proteins detected
for the single and triple TM mutants were comparable to those
observed for wild-type Env (Fig. 4C). Similar results were
obtained when we applied cellular ELISA to assess the cell surface
expression in CrFK cells of the single, double and triple Cys-to-Ser
mutants (data not shown). Taken together, these experiments
indicate that the defect in Env incorporation exhibited by the
double and triple mutants (Fig. 4B) cannot be attributed to
inefﬁcient expression of these mutant glycoproteins at the plasma
membrane.C8
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C804S, C811S, C815S and C804S/C811S/C815S were biotinylated as described in ‘‘Mate
pooled sera from FIV-infected cats, resolved by SDS-PAGE and transferred onto nitroce
conjugated horseradish peroxidase coupled to enhanced chemiluminescence. The mobil
the molecular weight standards.Palmitoylation of the FIV TM cytoplasmic domain
Covalent addition of the 16-carbon saturated fatty acid palmitate
is a post-translational modiﬁcation that affects the localization
and function of numerous cellular and viral proteins (Resh, 2006).
Palmitate is attached through a thioester bond to protein cysteine
residues that are at or near the membrane-spanning domain (Resh,
2006). This feature of this particular type of protein acylation led us
to speculate that FIV TM cysteines 804, 811 and 815, which are
proximal to the membrane-spanning region, could be potential sites
of protein palmitoylation.
We therefore ﬁrst examined whether the cytoplasmic domain
of the FIV TM is modiﬁed by the addition of palmitate. To this end,
we applied a recently developed method that, based on the
Click chemistry technology, allows the detection of palmitoylated
proteins with high sensitivity and speciﬁcity (Charron et al., 2009;
Martin and Cravatt, 2009). CrFK cells were transfected with the
wild-type FIV proviral DNA and metabolically labeled with azide-
conjugated palmitic acid. Cells were lysed and the FIV proteins
were immunoprecipitated, eluted from the immunocomplexes
and reacted with biotin-alkyne. As negative control, a sample of
immunoprecipitated FIV proteins derived from metabolically
labeled cells was not incubated with biotin-alkyne. The viral
proteins were then resolved by SDS-PAGE and transferred to a
nitrocellulose membrane. Fig. 5 shows that the FIV TM is modiﬁed
by palmitoylation as inferred from its detection using HRP-
conjugated streptavidin. The speciﬁcity of the reaction is demon-
strated by the fact that the TM is visualized only in the protein
sample that was incubated with biotin-alkyne (Fig. 5). Moreover,
treatment of metabolically labeled samples with hydroxylamineTM
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ibed in ‘‘Materials and methods’’. Viral proteins in the cell lysates and virions were
the CA protein. The mobilities of the TM and CA proteins are indicated as are those
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detection with streptavidin (data not shown).Localization of the palmitoylation sites in the FIV TM
To identify the sites at which the cytoplasmic domain of the
FIV TM glycoprotein is modiﬁed by the attachment of palmitic
acid, we performed metabolic labeling with palmitic acid-azide of
cells transfected with the proviral DNAs of the double mutants
C804S/C811S, C811S/C815S and C804S/C815S (the latter mutant
was constructed for the purpose of this experiment; Fig. 1). As
negative control, we included the triple mutant C804S/C811S/
C815S. The rationale behind this experiment was that with the
aid of the FIV Env double mutants we would be able to identify
which cysteines are palmitoylated. Surprisingly, the triple mutantTM
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Fig. 5. Palmitoylation of the FIV TM cytoplasmic domain. CrFK cells were
transfected with the wild-type FIV proviral DNA, metabolically labeled with
palmitic acid-azide, lysed and immunoprecipitated as described in ‘‘Materials
and methods’’. Viral proteins were then subjected to Click chemistry either in the
presence (þ) or in the absence () of biotin-alkyne, resolved by SDS-PAGE and
transferred to a nitrocellulose membrane. The membrane was ﬁrst incubated with
streptavidin-horseradish peroxidase conjugate (left panel) and then reprobed with
the anti-TM polyclonal serum (right panel). The mobility of the FIV TM protein is
indicated.
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Fig. 6. Identiﬁcation of the palmitoylation sites in the FIV TM cytoplasmic domain. (A
C804S/C815S and C804S/C811S/C815S proviral DNAs and metabolically labeled with p
subjected to Click chemistry to detect palmitate addition as described in ‘‘Materials an
the mutant C804S/C811S/C815S and C804S/C811S/C815S/C848S proviral DNAs were mein which cysteines 804, 811 and 815 are replaced by serines, was
found to be modiﬁed by palmitoylation (Fig. 6A). This result
suggested that the distal cysteine residue at Env position 848
might be also modiﬁed by the addition of palmitate.
We therefore created a mutant proviral DNA in which the four
cysteines within the TM cytoplasmic domain were replaced by
serines. When we compared the results of the metabolic labeling
with palmitic acid-azide of cells expressing the triple and quad-
ruple Env cysteine mutants with those obtained with wild-type
Env, we found that Env palmitoylation is abrogated only after
simultaneously substituting the four cysteine residues within the
FIV TM cytoplasmic tail (Fig. 6B).
Taken together, these data indicate that in the FIV TM protein
palmitic acid is attached not only to the membrane-proximal
cysteine residues, but to the distal cysteine 848 as well.
Triton X-100 solubility properties of wild-type and mutant FIV Env
glycoproteins
The results obtained at this point indicated that while both
C804S and C804S/C811S/C815S mutations were highly detrimen-
tal to Env fusion activity, the mutant C804S Env protein was
efﬁciently incorporated into virions whereas the triple mutant
glycoprotein was incapable of associating with particles. Taking
into account that it has been demonstrated in HIV-1 that a
substantial fraction of Gag is associated with lipid rafts
(Lindwasser and Resh, 2001; Nguyen and Hildreth, 2000; Ono
and Freed, 2001), we decided to examine whether the triple
substitution C804S/C811S/C815S impairs Env localization in
detergent-resistant membrane microdomains thereby preventing
Env packaging into Gag-made particles.
One property of lipid raft-associated proteins is their insolu-
bility in Triton X-100 at 4 1C (Brown and Rose, 1992). We there-
fore transfected 293T cells with the wild-type, C804S and C804S/
C811S/C815S proviral DNAs and subjected the cells to twoanti-TM
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Fig. 7. Triton X-100 solubility of the wild-type and mutant Env glycoproteins.
(A) 293T cells expressing wild-type (WT), C804S or C804S/C811S/C815S Env
proteins were extracted with Triton X-100 at 4 1C (left panel) or at 37 1C (right
panel), and soluble (S) and insoluble (I) fractions were obtained as described in
‘‘Materials and methods’’. The FIV glycoproteins were detected in each fraction
using the anti-SU MAb. (B) 293T cells that constitutively express ﬂotillin-1 as well
as 293T cells infected with a recombinant vaccinia virus directing the synthesis
of rotavirus VP7 were processed at 4 1C into the Triton X-100 soluble (S) and
insoluble (I) fractions and visualized by Western blotting as described in
‘‘Materials and methods’’. (C) 293T cells were transfected with the wild-type FIV
proviral DNA or a molecular clone expressing a nonmyristoylated version of the
Gag polyprotein (myr Gag). Cells were subjected to the Triton X-100 extraction
procedure at 4 1C and soluble (S) and insoluble (I) fractions were obtained by
centrifugation as described in ‘‘Materials and methods’’. Both the wild-type and
myr Gag proteins were detected by Western blotting using the MAb directed to
the CA domain of Gag.
S.A. Gonza´lez et al. / Virology 428 (2012) 1–10 7successive detergent extractions as described in ‘‘Materials and
methods’’. Cells were ﬁrst lysed in Triton X-100 at 4 1C and then
centrifuged so as to obtain the Triton-soluble material in the
supernatant. The pellet was resuspended in b-octylglucoside, a
detergent that disrupts lipid rafts, and centrifuged to recover the
Triton-insoluble material in the supernatant. We found that the
wild-type and mutant Env glycoproteins were mostly detected in
the Triton X-100 insoluble fractions (Fig. 7A). By contrast, when
the Triton X-100 extraction was performed a 37 1C instead of 4 1C,
the wild-type and mutant glycoproteins shifted from the insolu-
ble to the soluble fraction (Fig. 7A). Of note, when using the same
two-step detergent extraction method, we observed that the lipid
raft marker ﬂotillin-1 was recovered in the insoluble fraction,
whereas the rough endoplasmic reticulum integral membrane
glycoprotein rotavirus VP7 was solubilized by treatment with
Triton X-100 at 4 1C (Fig. 7B). Interestingly, most of the FIV Gag
protein was detected in the insoluble fraction (Fig. 7C). However,
a nonmyristoylated FIV Gag, which we have previously shown to
be incapable of plasma membrane binding (Manrique et al.,
2001b), was found in the soluble fraction (Fig. 7C). These results
indicate that under our experimental conditions the virion incor-
poration-defective C804S/C811S/C815S mutant Env glycoprotein
is as resistant to Triton X-100 extraction at 4 1C as wild-type Env.Discussion
The cytoplasmic domain of the FIV Env glycoprotein has four
highly conserved cysteine residues at positions 804, 811, 815 and
848. Cysteines 804, 811 and 815 are located in close proximity
to the TM membrane anchor occupying positions 1, 8 and 12,
respectively, in the cytoplasmic tail.
Given that divergent results have been reported with respect
to the functions played by the retroviral TM cytoplasmic cysteines
and their palmitoylation, we decided to investigate the relevanceof the FIV TM membrane-proximal cysteines 804, 811 and 815 for
Env biological properties. To this end, we constructed a series of
single, double and triple mutants in which cysteines 804, 811 and
815 were replaced, alone or in combination, by serines. When
these FIV Env mutants were phenotypically characterized, we
found that they were all expressed and processed into the SU and
TM subunits in a wild-type manner. By contrast, when we tested
the fusogenic capacity of the TM cysteine mutants, we observed
that substitution for serine of cysteines 804 or 811 drastically
reduced the ability of these glycoproteins to mediate cell-to-cell
fusion when compared with wild-type Env. A highly defective
fusion phenotype was also demonstrated for the double mutant
C804S/C811S and the triple mutant C804S/C811S/C815S. Inter-
estingly, replacement of cysteine 815 by serine allowed Env
fusion to proceed with an efﬁciency representing approximately
50% of that of wild-type Env. Taken together, our results clearly
indicate that cysteines 804 and 811 are critical for FIV Env
fusogenicity. It should be stressed that the defect in Env fusion
imposed by the C804S and C811S mutations cannot be attributed
to an impairment in Env transport to the plasma membrane since
these mutant Env glycoproteins are readily detected at the cell
surface at levels comparable to those of wild-type Env.
A crucial step in lentiviral morphogenesis is the incorporation
of Env into the Gag-made budding virions. In the case of SIV, we
have demonstrated by means of genetic, biochemical and pull-
down experiments that Env packaging into viral particles results
from a speciﬁc interaction between the Env cytoplasmic tail and
the matrix domain of the Gag protein (Celma et al., 2001;
Gonza´lez et al., 1996; Manrique et al., 2001a, 2003, 2008). The
same mechanism operates in HIV-1 (Freed and Martin, 1996;
Murakami and Freed, 2000). When we examined the ability of the
most relevant FIV Env cysteine mutants generated in this study to
associate with viral particles, we found that the substitution of
cysteines 804, 811 or 815 by serine do not affect Env incorpora-
tion into virions. However, the double C804S/C811S and the triple
C804S/C811S/C815S mutations abrogate Env packaging into par-
ticles. There are at least two possible explanations for the Env
incorporation defect exhibited by the double and triple Env
mutants. These amino acid substitutions may modify the struc-
ture of the FIV TM thereby impairing its association with Gag.
Alternatively, the double C804S/C811S and the triple C804S/
C811S/C815S mutations may alter the distribution of Env on the
plasma membrane which in turn may prevent its recruitment into
budding particles. However, the mutant Env glycoprotein lacking
the three most membrane-proximal cytoplasmic cysteines is
resistant to Triton X-100 extraction at low temperature, suggest-
ing that this protein is associated with lipid rafts. The same
behavior is exhibited by both wild-type Env and Gag. It is
therefore likely that the triple mutant Env glycoprotein is not
excluded from the virus assembly sites at the plasma membrane.
The fact that removal of three of the four palmitoylation sites
from the FIV Env glycoprotein does not appear to affect its cell
surface distribution is in line with the results of Yang et al. (2010)
showing that the two cytoplasmic palmitoylated cysteines in the
HIV-1 Env protein are not involved in its association with lipid
rafts. Instead, HIV-1 Env localization to detergent-resistant mem-
brane domains is promoted by molecular determinants present
within the C-terminal a-helix of the cytoplasmic tail (Yang et al.,
2010).
We have previously shown that removal of the entire FIV TM
cytoplasmic domain or the deletion of as many as six amino acids
into the membrane-spanning region blocks Env incorporation into
virions (Celma et al., 2007). However, the phenotype of these Env
mutants is explained by the instability of the SU-TM complex
exhibited by these glycoproteins, which causes SU secretion and TM
degradation (Celma et al., 2007). Therefore, mutations C804S/C811S
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described for the FIV TM cytoplasmic domain that abrogate Env
incorporation without affecting Env processing or cell surface
expression.
An important result stemming from our work is the demon-
stration, by means of the Click chemistry technology, that the FIV
TM cytoplasmic tail is palmitoylated and that the four highly
conserved cysteine residues within this Env domain are the sites
of this modiﬁcation. In this regard, the endodomain of the spike
glycoprotein of SARS-coronavirus bears nine cysteine residues, all
or most of which appear to be palmitoylated (Petit et al., 2007).
Although we expected that the best candidates for palmitoyla-
tion would be the membrane-proximal cysteines 804, 811, and
815, we found that the distal cysteine residue at position 848 is
acylated as well. Cysteine 848 is at a distance of 44 amino acids
from the TM membrane anchor. In this respect, in the Env
proteins of most HIV-1 and SIV isolates the TM cytoplasmic
cysteines that are modiﬁed by palmitate addition are also dis-
tantly located from the membrane-spanning domain (Yang et al.,
1995). We did not address in this work the role in Env function of
cysteine 848 because we have previously characterized an FIV
Env truncation mutant lacking the C-terminal 11 amino acids
(including cysteine 848) which showed a wild-type phenotype
with respect to fusion activity and Env incorporation into virions
(Celma et al., 2007).
In summary, we show here that the FIV TM cytoplasmic tail is
modiﬁed by the addition of palmitate to the four highly conserved
cysteine residues present in this Env domain. Moreover, our
results indicate that the two most membrane-proximal cysteines
(residues 804 and 811) are more essential to FIV functions than
cysteines 815 and 848, since mutants C804S and C811S are poorly
fusogenic and the simultaneous mutation of these residues
not only abrogates Env fusion ability but Env incorporation into
virions as well.Materials and methods
Cell lines
293T, CrFK and TZM-bl cells were grown in Dulbecco’s mod-
iﬁed Eagle’s medium supplemented with 10% fetal bovine serum
(FBS, GIBCO).
Monoclonal antibodies
Monoclonal antibodies used to detect FIV SU (SUFc1-30) and
CA proteins (PAK3-2C1) were obtained from the NIH Research
and Reference Reagent Program. Pooled sera from FIV-infected
cats were provided by Edward Hoover (Colorado State University,
USA). Detection of FIV TM protein was performed using a mouse
polyclonal antibody generated in our laboratory (Celma et al.,
2007).
Proviral DNA constructs and site-directed mutagenesis
All FIV Env mutant proviruses were derived from the infec-
tious molecular clone F-14 of the Petaluma isolate (Olmsted et al.,
1989). Mutation of the TM cytoplasmic domain was performed
by asymmetric PCR-based site-directed mutagenesis as we have
previously described using the Elongase enzyme high-ﬁdelity mix
(Invitrogen) and antisense oligonucleotides carrying the desired
mutations (Celma et al., 2007; Manrique et al., 2004). The single,
double and triple mutations affecting the TM cysteine residues at
Env positions 804, 811 and 815 were introduced into a SpeI-
NotI restriction fragment corresponding to nucleotides (nts)8287–9474 of the FIV genome. The SpeI-NotI fragments contain-
ing the corresponding mutations were substituted for the wild-
type counterpart in the parental FIV construct cloned in the
pSV-SPORT1 plasmid (Celma et al., 2007). We have previously
generated an FIV proviral DNA lacking the U3 element of the 50
long terminal repeat (LTR) which was cloned immediately down-
stream of the pcDNA human early cytomegalovirus promoter
(Celma et al., 2007). This construct, denominated pcDNAFIVDU3,
allows the expression of the FIV viral proteins in human cells
(Celma et al., 2007; Poeschla and Looney, 1998). The pSV-SPORT1
constructs carrying the mutant proviral DNAs were digested with
KpnI and NotI, and the resulting fragments (nts 6398–9474 of the
FIV genome) were subcloned into the KpnI and NotI sites of the
pcDNAFIVDU3.
Transfections and viral protein analysis
CrFK or 293T cells (grown in 60-mm-diameter dishes) were
transfected with 8 mg of wild-type or mutant proviral DNAs using
Lipofectamine 2000 (Invitrogen). 48 h post-transfection cells were
washed with ice-cold phosphate-buffered saline (PBS) and lysed
at 4 1C in buffer containing 50 mM Tris–HCl (pH 8.0), 150 mM
NaCl, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate,
1 mM phenylmethylsulfonyl ﬂuoride (PMSF) and 10 mg/ml apro-
tinin followed by a 5-min centrifugation at 16,000g to remove
cellular debris. Culture supernatants from the transfected cells
were ﬁltered through 0.45-mm-pore-size ﬁlters (Corning). Cell
lysates and clariﬁed supernatants were resolved by SDS-PAGE,
blotted onto nitrocellulose membranes and analyzed by Western
blotting using the MAbs directed to the SU and CA proteins or the
anti-TM polyclonal serum. Western blots were developed with
ECL Advance reagent (GE Life Sciences). Protein band signals were
quantitated as previously described (Celma et al., 2007; Rauddi
et al., 2011).
Analysis of Env incorporation into virions
Virions were pelleted from the cell-free culture supernatants of
transfected CrFK cells by ultracentrifugation (100,000g, 90 min,
4 1C) through a 20% (w/v) sucrose cushion as we have previously
described (Celma et al., 2007; Manrique et al., 2004). Virion-
associated proteins were resolved by SDS-PAGE and analyzed by
Western blotting using the PAK3-2C1 MAb to visualize the Gag and
CA proteins, and the mouse anti-TM serum to detect the FIV TM.
Cellular ELISA
To determine the cell surface levels of FIV Env, 293T or CrFK
cells were transfected with the wild-type or mutant proviral
DNAs as described above. 48 h post-transfection, triplicate sam-
ples corresponding to 3105 cells were ﬁrst washed with ice-
cold PBS and resuspended in 50 ml of ELISA buffer (PBS containing
0.4% bovine serum albumin [BSA] and 0.1% sodium azide). Cells
were incubated with 10 mg/ml anti-SU SUFc1-30 MAb for 1 h at
4 1C, washed 3 times with ice-cold ELISA buffer and exposed
to 10 mg/ml HRP-conjugated anti-mouse IgG (Promega) for 1 h
at 4 1C. Cells were washed 3 times with ELISA buffer and the
enzymatic reaction was performed using the 2,20-azinobis-(3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS) substrate. The result-
ing colored reaction signal was measured on a microtiter plate
ELISA reader (Biorad) at 405 nm (reference wavelength 490 nm) as
we have previously described (Rauddi et al., 2011). Non-trans-
fected cells incubated with the secondary antibody were used as a
negative control. Moreover, to corroborate that under our experi-
mental conditions only cell surface proteins are detected, we
carried out the cellular ElLISA protocol described above using a
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body (Sigma-Aldrich).
To quantitate total cellular Env expression, 105 transfected
cells were ﬁxed with 4% (w/v) paraformaldehyde in PBS for
15 min at room temperature, rinsed 3 times in PBS and permea-
bilized with 0.1% (v/v) Triton X-100 for 15 min at room tempera-
ture. After washing the cells 3 times with PBS, they were
resuspended in PBS containing 0.4% BSA and successively incu-
bated with the anti-SU MAb and the HRP-conjugated anti-mouse
antibody. Enzyme activity was measured in an ELISA reader as
described above.
Cell surface biotinylation
Biotinylation of surface proteins in transfected cells was per-
formed essentially as we have previously reported (Affranchino
and Gonza´lez, 2006; Celma et al., 2007). Transfected CrFK cells
were incubated for 30 min at 4 1C with the membrane-imperme-
able biotinylating reagent biotinamidocaproate N-hydroxy-
succinamide ester (ECL Protein Biotinylation System, GE Life
Sciences). Cells were washed twice with ice-cold PBS and lysed
as described above. Viral proteins were immunoprecipitated with
pooled sera from FIV-infected cats, resolved by SDS-PAGE and
transferred onto nitrocellulose membranes. Cell surface proteins
were detected by HRP-conjugated streptavidin and ECL.
Cell–cell fusion assays
To investigate the fusogenic capacity of the mutant FIV Env
proteins we performed a cell-to-cell fusion assay that we have
recently developed (Celma et al., 2007). Brieﬂy, 293T cells were
transfected with the wild-type and mutant pcDNAFIVDU3 con-
structs together with an HIV-1 Tat-expressing plasmid created in
our laboratory (Celma et al., 2007). 48 h post-transfection, the
cells were dissociated and equivalent number of cells were added
at a 1:5 ratio to 4104 TZM-bl cells in 24-well plates. TZM-bl
cells are HeLa derivatives that express high levels of CD4 and both
CXCR4 and CCR5 coreceptors and carry the b-galactosidase gene
under the control of the HIV-1 LTR (Wei et al., 2002). Coculture of
transfected 293T and indicator TZM-bl cells was continued for
48 h after which cells were stained for b-galactosidase activity
and scored for syncytia formation as previously described (Celma
et al., 2007). Cell-to-cell fusion was quantitated as the total
number of blue syncytia per well by ﬁrst counting their number
in at least 20 nonoverlapping ﬁelds. The average number of
syncytia per ﬁeld was multiplied by the total number of ﬁelds
per well and the result was referred to that obtained for wild-type
Env. In the case of Env mutants yielding low number of syncytia,
the entire wells were examined and the total number of blue
syncytia was counted. The CXCR4 antagonist AMD3100 was
purchased from Sigma-Aldrich.
Metabolic labeling with palmitic acid and Click chemistry
To examine whether the cytoplasmic domain of the FIV TM is
modiﬁed by the addition of palmitic acid we performed metabolic
labeling of FIV Env-expressing cells with palmitic acid-azide
followed by detection of its incorporation into the TM protein
using Click chemistry (Charron et al., 2009; Martin and Cravatt,
2009). Namely, CrFK cells (grown in 35-mm-diameter dishes)
were transfected in duplicate with wild-type or mutant proviral
DNAs. At 48 h post-transfection, cells were incubated during 1 h
in FBS-free DMEM after which cells were metabolically labeled
with 100 mM palmitic acid-azide (Invitrogen) for 6 h in DMEM
supplemented with 2.5% (v/v) FBS. Cells were washed twice with
ice-cold PBS and lysed as described above. Cell lysates wereimmunoprecipitated with pooled sera from FIV-infected cats and
immunocomplexes were eluted from the protein A-Sepharose
beads by incubation at 80 1C during 15 min in buffer containing
50 mM Tris–HCl (pH 8.0), 1% SDS, 1 mM PMSF and 10 mg/ml
aprotinin. The eluates containing the FIV proteins were subjected
to Click chemistry using the Click-iT Metabolic Labeling Reagents
for Proteins (Invitrogen). The viral proteins obtained from one set
of transfections were incubated with 20 mM biotin-alkyne (Invi-
trogen) in the presence of 2 mM CuSO4 as catalyst during 20 min
at room temperature. The reaction was stopped by the addition of
3 volumes methanol, 0.75 volumes chloroform and 2 volumes
water and centrifuged at 16,000g during 5 min. Proteins present in
the interface layer were precipitated by the addition of methanol,
centrifuged at 16,000g during 5 min. The protein pellets were air-
dried and resuspended in non-reducing loading buffer. The other
set of protein samples was treated likewise except that the biotin-
alkyne reaction step was omitted. All samples were separated by
SDS-PAGE and transferred to nitrocellulose membranes. Mem-
branes were ﬁrst incubated with HRP-conjugated streptavidin to
visualize the palmitoylated proteins and then reprobed with the
mouse polyclonal anti-TM serum.
Triton X-100 solubilization assay
To evaluate the solubility in Triton X-100 of wild-type and
mutant Env glycoproteins we followed a protocol similar to that
described by Adam et al. (2008) but with several modiﬁcations.
293T cells were transfected with the wild-type, C804S or C804S/
C811S/C815S proviral DNAs, and 48 h post-transfection cells were
washed twice with ice-cold PBS and lysed on ice for 5 min in a
solution containing 0.2% Triton X-100, 50 mM Tris–HCl (pH 8.0),
150 mM NaCl, 50 mM KCl, 10 mM MgCl2, 10 mM EGTA, 5 mM
dithiothreitol and protease inhibitors. Cell lysates were then
centrifuged at 16,000g for 60 min at 4 1C. The supernatants
containing the detergent-soluble fractions were separated from
the pellets corresponding to the Triton X-100 insoluble material.
The pellets were resuspended in a lysis solution with a composi-
tion similar to that described above but containing 60 mM
b-octylglucoside instead of Triton X-100. The samples were
incubated on ice for 10 min and centrifuged as described above.
The two sets of supernatants resulting from the two-step deter-
gent extraction method were immunoprecipitated with pooled
sera from FIV-infected cats, subjected to SDS-PAGE and trans-
ferred to nitrocellulose membranes. FIV Env proteins were
detected by Western blotting using the anti-SU MAb whereas
FIV Gag was visualized with the MAb directed to the CA domain.
Non-transfected 293T cells were subjected to the same two-step
detergent extraction assay described above and the lipid raft-
associated protein ﬂotillin-1 was visualized in the resulting
supernatants with a MAb (BD Biosciences) kindly provided
by Eduardo Castan˜o (Leloir Institute, Argentina). Rotavirus VP7
(SA11 strain) was expressed in 293T cells using a recombinant
vaccinia virus as we have previously described (Celma et al.,
2001) and detected by means of an anti-SA11 polyclonal rabbit
serum. To express nonmyristoylated FIV Gag, we transfected 293T
cells with a proviral DNA in which the codon for the glycine
residue at position 2 in the gag open reading frame was mutated
to alanine (Manrique et al., 2001b).Acknowledgments
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